A teenager with fever, chest pain, and respiratory distress during the coronavirus disease 2019 pandemic: a lesson on anchoring bias
Journal: 2020/October - Emergency
Abstract:
Symptoms of coronavirus disease 2019 overlap with other important illnesses affecting young adults. We report a case of a 17-year old male presenting to the emergency department in the midst of a pandemic with symptoms of coronavirus disease 2019. He had fever, dyspnea, chest pain, and myalgias, with bilateral infiltrates on chest radiograph, and developed septic shock secondary to infectious thromboembolic events. However, his blood cultures grew group G streptococcus secondary to his oropharyngeal infection, and he experienced an infectious thrombus in the internal jugular vein, consistent with the rare but well-described Lemierre's syndrome. This case report calls attention to the importance of maintaining differential diagnoses and thereby minimizing the biases and assumptions that come with clinical care during a pandemic.
Keywords: COVID‐19; fever.
Relations:
Content
Diseases
(2)
Conditions
(3)
Organisms
(2)
Anatomy
(1)
Similar articles
Articles by the same authors
Discussion board
J Am Coll Emerg Physicians Open undefined

A teenager with fever, chest pain, and respiratory distress during the coronavirus disease 2019 pandemic: a lesson on anchoring bias

Department of Emergency and Hospital Medicine/University of South Florida, Morsani College of Medicine, Lehigh Valley Health Network, Allentown Pennsylvania, USA,
Lehigh Valley Health Network, Department of Emergency and Hospital Medicine, Division of Pediatric Emergency Medicine/University of South Florida, Morsani College of Medicine, Allentown Pennsylvania, USA,
Michele N. Karn, Email: ude.fsu@nrakm.
Corresponding author.
Correspondence
Michele N. Karn, BS, LVH‐M‐5th Floor EM Residency S, 2545 Schoenersville Road, Bethlehem, PA 18017, USA.
Email: ude.fsu@nrakm,
Received 2020 Aug 5; Revised 2020 Aug 25; Accepted 2020 Aug 3.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

Abstract

Symptoms of coronavirus disease 2019 overlap with other important illnesses affecting young adults. We report a case of a 17‐year old male presenting to the emergency department in the midst of a pandemic with symptoms of coronavirus disease 2019. He had fever, dyspnea, chest pain, and myalgias, with bilateral infiltrates on chest radiograph, and developed septic shock secondary to infectious thromboembolic events. However, his blood cultures grew group G streptococcus secondary to his oropharyngeal infection, and he experienced an infectious thrombus in the internal jugular vein, consistent with the rare but well‐described Lemierre's syndrome. This case report calls attention to the importance of maintaining differential diagnoses and thereby minimizing the biases and assumptions that come with clinical care during a pandemic.

Keywords: COVID‐19, fever
Abstract
Symptoms of coronavirus disease 2019 overlap with other important illnesses affecting young adults. We report a case of a 17‐year old male presenting to the emergency department in the midst of a pandemic with symptoms of coronavirus disease 2019. He had fever, dyspnea, chest pain, and myalgias, with bilateral infiltrates on chest radiograph, and developed septic shock secondary to infectious thromboembolic events. However, his blood cultures grew group G streptococcus secondary to his oropharyngeal infection, and he experienced an infectious thrombus in the internal jugular vein, consistent with the rare but well‐described Lemierre's syndrome. This case report calls attention to the importance of maintaining differential diagnoses and thereby minimizing the biases and assumptions that come with clinical care during a pandemic.
A previously healthy 17‐year‐old male presented to the emergency department (ED) with a 7‐day history of worsening symptoms, including left‐sided sore throat, chills, diarrhea, vomiting, diffuse body aches, right‐sided chest pain, and persistent fever. Throughout the past week, he had several outpatient and ED evaluations, including negative testing for strep pharyngitis, influenza, mononucleosis, and Epstein‐Barr virus. He also had 2 nasal swab specimens collected for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus testing. Both were polymerase chain reaction tests, and both were eventually negative. He had been discharged to home with advice on supportive care, including antipyretics and good oral hydration. On this presentation, he had a 97% pulse oximetry on room air, and he was febrile and tachycardic and had marked diastolic hypotension. He had erosions in the left posterior tonsil, an exudative oropharynx, diminished breath sounds bilaterally, and progressively worsening respiratory distress. Laboratory results demonstrated leukopenia as well as markedly elevated D‐dimer, C‐reactive protein, and procalcitonin. Chest radiograph showed bilateral nodular densities with ground‐glass, interpreted as multilobar pneumonia. He was fluid resuscitated, administered broad‐spectrum antibiotics, and given nasal cannula oxygen. He was admitted to an isolation floor for patients suspected to have coronavirus disease 2019 (COVID‐19) while his third SARS‐CoV‐2 virus polymerase chain reaction test was pending.
A non‐occlusive thrombus of his left internal jugular vein was found on computed tomography imaging. His blood cultures revealed group G streptococcus, and he was initially treated with clindamycin, vancomycin, ceftriaxone, and ampicillin/sulbactam for 2 days. He was diagnosed with Lemierre's syndrome and group G strep sepsis. A later blood culture found Fusobacterium necrophorum; on this finding, his antibiotics were switched to meropenum.
Throughout the length of his stay, the patient experienced severe chest pain, presumably from septic micro emboli. He received pain medication for his chest pain and had worsening hypoxemia and respiratory distress (accessory muscle use and increasing respiratory rates) during the first 3 days of his hospital stay. He had worsening edema on his chest radiograph without improvement with furosemide, was subsequently transferred to the pediatric ICU on hospital day 4, and was placed on bilevel positive airway pressure to maintain adequate oxygen levels. He had a peripherally inserted central catheter on hospital day 5. Despite antibiotics, he continued to have worsening symptoms, and an effusion developed on his chest radiograph. On hospital day 7, a chest tube was introduced into his right lung that drained punch‐colored sterile pleural fluid. Thereafter he was easily weaned off the oxygen support and was transitioned to room air. His D‐dimer increased further, and his laboratory results showed increasing thrombocytosis. Considering the potential for his peripherally inserted central catheter line to clot during this thromboembolic illness, hematology was consulted and agreed he should be treated with enoxaparin.
On discharge, an ultrasound demonstrated resolution of the internal jugular thrombus, and his blood cultures were sterile. He was discharged on hospital day 13. He completed outpatient parenteral antibiotic therapy through a peripherally inserted central catheter with 24 days of ertapenem and enoxaparin. He had frequent follow‐up with pediatric infectious disease and made a complete recovery.
Lemierre's syndrome is a rare disease that is estimated to have a worldwide incidence of 1/1,000,000. 1 It occurs when an oropharyngeal infection spreads into deep spaces within the neck, causing septic thrombophlebitis and possible spreading septicemia if not caught early. 2 , 3 Typically, F. necrophorum is involved, causing a bloodstream infection and promoting the formation of septic emboli, which can migrate to pulmonary capillaries 1 , 4 , 5 Typical treatment for Lemierre's syndrome involves intravenous antibiotics to treat the underlying pathogens. The use of anticoagulation medication, such as low‐molecular weight heparin, is considered controversial, as limited research has been done with regard to its effectiveness in Lemierre's syndrome. 4 , 6 This patient was evaluated in the midst of a COVID‐19 pandemic in a geographic area that was greatly affected by the high prevalence of SARS‐CoV‐2. Despite a sore throat, he was triaged into an ED pod for cohorted patients with suspected COVID‐19. This initial decision could potentially have led to further cognitive errors on the part of the treatment team. Putting too much weight on this initial presentation of fever in a pandemic would have been consistent with “anchoring bias” in which initial facts distort the clinician's ability to take in further information objectively. 7 It has been well established that clinicians who succumb to anchoring effects are more likely to make diagnostic errors. 8 , 9 , 10 , 11 Despite the patient's initial findings, some of which could have been consistent with the frequently encountered clinical deterioration with acute COVID‐19, the ED team recognized alternative diagnoses for his persistent fevers, tachycardia, and hypotension and appropriately treated his septic shock with broad‐spectrum antibiotics and fluid resuscitation. Although our case is similar to the characteristic clinical picture of Lemierre's syndrome resulting from strep pharyngitis, the diagnosis was complicated by a group G streptococcus infection. The rapid antigen detection testing is highly specific for group A strep, but does not reliably identify group G strep. 12 This case is further complicated by the lack of data concerning the reliability of SARS‐CoV‐2 viral testing. This patient was tested multiple times and suspicion remained high even after negative results. The sensitivity of this testing varies by type of specimen obtained, and there is a lack of gold standard testing for comparison. The reported sensitivity of nasopharyngeal specimens appears to vary between studies, all with relatively few participants. A discussion by Woloshin et al 13 in the New England Journal of Medicine notes that a preprint study from Wuhan, China, found that among 490 nasal swabs from 213 hospitalized patients with COVID‐19, 27% were falsely negative. A systematic review by Arevalo‐Rodriguez et al 14 suggested that the false negative rate could be between 2%–29%, equating to 71%–98% sensitivity. Because there are still many unknown factors, such as variations between time of testing and stage of disease, a negative COVID‐19 result currently does not reliably exclude the disease.
This case report summarized the presentation and treatment of a 17‐year‐old male who was ultimately diagnosed with Lemierre's syndrome days after being treated as a presumed COVID‐19 case. Although he was successfully treated for Lemierre's syndrome, this case illustrates the importance of exploring various diagnoses even when symptoms are consistent with the disease of a current global pandemic.
The authors have no additional outside support information, conflicts, or financial interest to disclose.
We acknowledge Marna Rayl Greenberg for formatting and editing. The article publishing fees for this manuscript were generously provided by a nonprofit community foundation, the Dorothy Rider Pool Health Care Trust Awards for Clinical Transformational Excellence.

Notes

Karn MN, Johnson NP, Yaeger SK, Fugok KL. A teenager with fever, chest pain, and respiratory distress during the coronavirus disease 2019 pandemic: a lesson on anchoring bias. JACEP Open. 2020;1–3. 10.1002/emp2.12261 [CrossRef]

Funding and support: By JACEP Open policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist.

Supervising Editor: Faheem W. Guirgis, MD.

Notes
Karn MN, Johnson NP, Yaeger SK, Fugok KL. A teenager with fever, chest pain, and respiratory distress during the coronavirus disease 2019 pandemic: a lesson on anchoring bias. JACEP Open. 2020;1–3. 10.1002/emp2.12261 [CrossRef]

References

  • 1. Allen BW, Bentley TP. Lemierre syndrome.. Updated May 14, 2019. Accessed January 14, 2020.
  • 2. Eilbert W, Singla N. Lemierre's syndrome. Int J Emerg Med. 2013;6(1):40.
  • 3. Riordan T. Lemierre's syndrome: more than a historical curiosa. Postgrad Med J. 2004;80(944):328‐334.
  • 4. Karkos PD, Asrani S, Karkos CD, et al. Lemierre's syndrome: a systematic review. Laryngoscope. 2009;119(8):1552‐1559. [[PubMed]
  • 5. Osowicki J, Kapur S, Phuong LK, Dobson S. The long shadow of Lemierre's syndrome. J Infect. 2017;74:S47‐S53. [[PubMed]
  • 6. Johannesen K, Bodtger U. Lemierre's syndrome: current perspectives on diagnosis and management. Infect Drug Resist. 2016;9:221‐227.
  • 7. Gustavo S, Redelmeier D, Ruff C, Tobler P. Cognitive biases associated with medical decisions: a systematic review. BMC Med Inform Decis Mak. 2016;16(1):138.
  • 8. Perneger TV. Doctors and patients’ susceptibility to framing bias: a randomized trial. J Gen Intern Med. 2011;26(12):1411‐1417.
  • 9. Yee LM, Liu LY, Grobman WA. The relationship between obstetricians’ cognitive and affective traits and their patients’ delivery outcomes. Am J Obstet Gynecol. 2015;213(3):413.e1‐7. [[PubMed]
  • 10. Sorum PC, Shim J, Chasseigne G, Bonnin‐Scaon S, Cogneau J, Mullet E. Why do primary care physicians in the United States and France order prostate‐specific antigen tests for asymptomatic patients?. Med Decis Making. 2003;23(4):301‐313. [[PubMed]
  • 11. Stiegler MP, Ruskin KJ. Decision‐making and safety in anesthesiology. Curr Opin Anaesthesiol. 2012;25(6):724‐729. [[PubMed]
  • 12. Banerjee D, Selvarangan R. The evolution of group a streptococcus pharyngitis testing. Clinical Laboratory News. . Published 2018. Accessed August 24, 2020. [PubMed]
  • 13. Woloshin S, Patel N, Kesselheim AS, False negative tests for SARS‐COV‐2 infection—challenges and implications. N Engl J Med. 2020;383:e38. [[PubMed]
  • 14. Arevalo‐Rodriguez I, Buitrago‐Garcia D, Simancas‐Racines D, et al. False negative results of initial RT‐PCR assays for COVID‐19: a systematic review. medRxiv 2020. 10.1101/2020.04.16.20066787. [[PubMed]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.